Evaluating the Role of HLA-DRB1 Alleles in Genetic Predisposition to Psoriatic Arthritis in Patients with Psoriasis

International Journal of Medical Science

© 2024 by SSRG - IJMS Journal

Volume 11 Issue 1

Year of Publication : 2024

Authors : Rana Ahmad, Fouz Hassan, Faisal Redwan, Haissam Yazigi

10.14445/23939117/IJMS-V11I1P105

How to Cite?

Rana Ahmad, Fouz Hassan, Faisal Redwan, Haissam Yazigi, "Evaluating the Role of HLA-DRB1 Alleles in Genetic Predisposition to Psoriatic Arthritis in Patients with Psoriasis," SSRG International Journal of Medical Science, vol. 11,  no. 1, pp. 22-29, 2024. Crossref, https://doi.org/10.14445/23939117/IJMS-V11I1P105

Abstract:

Psoriasis is considered a chronic disease among the most common inflammatory autoimmune skin diseases. Psoriatic arthritis PsA is the most important systemic manifestation of psoriasis and often appears after the onset of psoriasis. HLA genes are considered the most important predisposing genetic factors associated with psoriasis, especially HLA-C*06, but the association between HLA-DRB1 alleles and psoriasis, in addition to the risk of developing PSA has not been widely studied since this association tends to differ between ethnic groups. The HLA-DRB1 alleles were identified in 50 patients with psoriasis in addition to 30 healthy patients using the sequence-specific primers PCR. Psoriasis patients were classified into two groups according to the presence of arthritis. 40% of patients had arthritis. Susceptibility to psoriasis in this study sample was significantly associated with HLA-DRB1*07, *11 and *10 (odds ratio (OR) 8.5, 4 and 3, p-value= 0.002, 0.02 and 0.01 respectively), While a negative association was found with HLA-DRB1*03 ((OR) 0.1). It was also observed that the presence of alleles *07, *11 and *01 is associated with a high risk of developing PsA in psoriasis patients ((OR) 14, 4.88 and 4.84, respectively). In contrast, alleles *03 and *14 were considered protective alleles against developing PSA in psoriasis patients ((OR) 0.14 and 0.2, respectively). Genetic associations identified in psoriasis have been found to be significantly associated with PsA. It is important to conduct genetic studies to determine the genetic factors involved in the pathogenic mechanism and thus reach a more effective treatment.

Keywords:

DRB1 alleles, HLA, Psoriasis, Psoriatic arthritis, Genetic predisposition.

References:

[1] Ivana Shawkatová et al., “HLA-C, DRB1 and DQB1 Alleles Involved in Genetic Predisposition to Psoriasis Vulgaris in the Slovak Population,” Folia Microbiologica, vol. 58, pp. 319-324, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Simonetta Trabace, “HLA and Disease Association,” The Journal of Headache and Pain, vol. 1, pp. 109-113, 2000.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Ruby J. Siegel, S. Louis Bridges Jr, and Salahuddin Ahmed, “HLA-C: An Accomplice in Rheumatic Diseases,” ACR Open Rheumatol, vol. 1, no. 9, pp. 571-579, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Yi-Wei Huang, and Tsen-Fang Tsai, “HLA-Cw1 and Psoriasis,” American Journal of Clinical Dermatology, vol. 22, pp. 339-347, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[5] World Health Organization, Global Report on Psoriasis, World Health Organization, pp. 1-49, 2016.
[Google Scholar] [Publisher Link]
[6] Wei-Chih Ko, Tsen-Fang Tsai, and Chao-Hsiun Tang, “Health State Utility, Willingness to Pay, and Quality of Life Among Taiwanese Patients with Psoriasis,” Dermatologica Sinica, vol. 34, no. 4, pp. 185-191, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Kuan-Chen Chen et al., “The Economic Burden of Psoriatic Diseases in Taiwan,” Journal of Dermatological Science, vol. 75, no. 3, pp. 183-189, 2014.
[CrossRef] [Google Scholar] [Publisher Link]
[8] Frank O. Nestle, Daniel H. Kaplan, and Jonathan Barker, “Mechanisms of Disease Psoriasis,” The New England Journal of Medicine, vol. 361, pp. 496-509, 2009.
[CrossRef] [Google Scholar] [Publisher Link]
[9] L. Chen,and T.F. Tsai, “HLA-Cw6 and Psoriasis,” British Journal of Dermatology, vol. 178, no. 4, pp. 854-862, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[10] Christopher E. M. Griffiths et al., Rook’s Textbook of Dermatology, 9th ed., General & Introductory Medical Science, John Wiley & Sons, vol. 4, pp. 1- 4696, 2016.
[Google Scholar] [Publisher Link]
[11] P.Y.P.C. Ho et al., Investigating the Role of the HLA-Cw*06 and HLA-DRB1 Genes in Susceptibility to Psoriatic Arthritis: Comparison with Psoriasis and Undifferentiated Inflammatory Arthritis, Annals of the Rheumatic Diseases, pp. 677-682, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[12] April W. Armstrong, and Charlotte Read, “Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review,” JAMA, vol. 323, no. 19, pp. 1945-1960, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[13] Meixin Shen et al., “HLA Correlations with Clinical Phenotypes and Risk of Metabolic Comorbidities in Singapore Chinese Psoriasis Patients,” Molecular Diagnosis & Therapy, vol. 23, pp. 751-760, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Thomas J. Russell, Lorain M. Schultes, and Donald J. Kuban, “Histocompatibility (HL-A) Antigens Associated with Psoriasis,” The New England Journal of Medicine, vol. 287, pp. 738-740, 1972.
[CrossRef] [Google Scholar] [Publisher Link]
[15] W. Brenner, F. Gschnait, and W. R. Mayr, “HLA B13, B17, B37 and Cw6 in Psoriasis Vulgaris: Association with the Age of Onset,” Archives of Dermatological Research, vol. 262, pp. 337-339, 1978.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Flavia de Freire Cassia et al, “Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population,” Psoriasis: Targets and Therapy, vol. 11, pp. 41-51, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[17] J.T. Elder et al., “The Genetics of Psoriasis 2001: The Odyssey Continues,” Arch Dermatol, vol. 137, no. 11, pp. 1447-1454 2001.
[CrossRef] [Google Scholar] [Publisher Link]
[18] U. Shankarkumar, A. Shankarkumar, and K. Ghosh, “Human Leukocyte Antigen (HLA) Cw Allele Association among Psoriasis Patients from Western India,” International Journal of Medicine and Medical Sciences, vol. 3, no. 14, pp. 396-399, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Abdulwahab S. Al-Fouzan, and Arti Nanda, “A Survey of Childhood Psoriasis in Kuwait,” Pediatric Dermatology, vol. 11, no. 2, pp. 116-119, 1994.
[CrossRef] [Google Scholar] [Publisher Link]
[20] Saeeda Munir et al., “The Association of HLA Alleles and Haplotypes with Age of Disease Onset in Pakistani Psoriatic Patients,” Immunology and Allergy, vol. 184, no. 2, pp. 202-210, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[21] C. Bejerano et al., “AB0574 Prevalence of Hla-Drb1 in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis: Comparison with Healthy Controls,” Annals of the Rheumatic Diseases, vol. 72, no. 3, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Dafna D Gladman et al., “HLA-DRB1∗04 Alleles in Psoriatic Arthritis: Comparison with Rheumatoid Arthritis and Healthy Controls,” Human Immunology, vol. 62, no. 11, pp. 1239-1244, 2001.
[CrossRef] [Google Scholar] [Publisher Link]
[23] Marcus Schmitt-Egenolf et al., “Oligonucleotide Typing Reveals Association of Type I Psoriasis with the HLA-DRB1*0701/2, - DQA*0201, -DQB1*0303 Extended Haplotype,” Journal of Investigative Dermatology, vol. 100, no. 6, pp. 749-752, 1993.
[CrossRef] [Google Scholar] [Publisher Link]
[24] Chaimaa Benlabsir et al., “HLA-C Genotyping Reveals Haplotype C*07 as a Potential Biomarker of Late Psoriasis Onset in Moroccan Patients,” Current Issues in Molecular Biology, vol. 45, no. 2, pp. 1012-1023, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[25] J.C. Woodrow, and A. Ilchysyn, “HLA Antigens in Psoriasis and Psoriatic Arthritis,” Journal of Medical Genetics, vol. 22, pp. 492-495, 1985.
[CrossRef] [Google Scholar] [Publisher Link]
[26] Farhat Fatema et al., “Early-Onset versus Late-Onset Psoriasis: A Comparative Study of Clinical Variables, Comorbidities, and Association with HLA CW6 in a Tertiary Care Center,” Indian Journal of Dermatology, vol. 66, no. 6, pp. 1-705, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[27] Tilo Henseler, and Enno Christophers, “Psoriasis of Early and Late Onset: Characterization of Two Types of Psoriasis Vulgaris,” Journal of the American Academy of Dermatology, vol. 13, no. 3, pp. 450-456, 1985.
[CrossRef] [Google Scholar] [Publisher Link]
[28] P. Rahman, and J.T. Elder, “Genetic Epidemiology of Psoriasis and Psoriatic Arthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 37-39, 2005.
[CrossRef] [Google Scholar] [Publisher Link]
[29] Amer Ejaz et al., “Presentation of Early Onset Psoriasis in Comparison with Late Onset Psoriasis: A Clinical Study from Pakistan,” Indian Journal of Dermatology, Venereology and Leprology, vol. 75, pp. 36-40, 2009.
[CrossRef] [Google Scholar] [Publisher Link]
[30] Nhi Thi Uyen Pham, Thuong Van Nguyen, and Hao Trong Nguyen, “HLA-Cw6 Increases the Risk of Psoriasis and Early Onset Before Twenty-Seven Years of Age among the Vietnamese Population,” Dermatology Reports, pp. 1-15, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[31] Yin-Ku Lin et al., “Psoriasis Patients with Specific HLA-Cw Alleles and Lower Plasma IL-17 Level Show Improved Response to Topical Lindioil Treatment,” Pharmacogenomics and Personalized Medicine, vol. 15, pp. 515-524, 2022.
[CrossRef] [Google Scholar] [Publisher Link]
[32] Michelle L. M. Mulder et al., “Clinical, Laboratory, and Genetic Markers for the Development or Presence of Psoriatic Arthritis in Psoriasis Patients: A Systematic Review,” Arthritis Research & Therapy, vol. 23, pp. 1-22, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[33] Chika Ohata et al., “Clinical Characteristics of Patients with Psoriasis with Family History: A Multicenter Observational Study,” The Journal of Dermatology, vol. 50, no. 6, pp. 746-752, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[34] Vinh Ngo Minh et al., “The Relationship between HLA-B27, HLA-Cw06, HLA-DR7 and Psoriatic Arthritis in Vietnamese Patients: Disease Progression and Therapeutic Burden,” Open Access Macedonian Journal of Medical Sciences, vol. 7, no. 2, pp. 300-301, 2019.
[Google Scholar] [Publisher Link]
[35] Hsien-Tzung Liao et al., “Human Leukocyte Antigen and Clinical and Demographic Characteristics in Psoriatic Arthritis and Psoriasis in Chinese Patients,” The Journal of Rheumatology, vol. 35, no. 5, pp. 891-895, 2008.
[Google Scholar] [Publisher Link]
[36] Mustafa Atasouy et al., “Association of HLA Class I and Class II Alleles with Psoriasis Vulgaris in Turkish Population. Influence of Type I and II Psoriasis,” Saudi Medical Journal, vol. 27, no. 3, pp. 373-376, 2006.
[Google Scholar] [Publisher Link]
[37] FF Cassia et al., “Psoriasis Vulgaris and Human Leukocyte Antigens,” Journal of the European Academy of Dermatology and Venereology, vol. 21, no. 3, pp. 303-310, 2007.
[CrossRef] [Google Scholar] [Publisher Link]
[38] Chi-Zai Sin et al., “Human Leukocyte Antigen and Demographic Characteristics in Chinese Patients with Active Peripheral Type Psoriatic Arthritis who had Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in a sIngle Dermatologic Clinic,” PloS One, vol. 14, no. 1, pp. 1-13, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[39] Rubén Queiro et al., “HLA-DR17 is Associated with Enthesitis in Psoriatic Arthritis,” Joint Bone Spine, vol. 78, no. 4, pp. 428-429, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[40] Claudia Bueno Cardoso et al., “Association between Psoriasis Vulgaris and MHC-DRB, -DQB Genes as a Contribution to Disease Diagnosis,” European Journal of Dermatology, vol. 15, no. 3, pp. 159-163, 2005.
[Google Scholar] [Publisher Link]